Educational guide
SS-31 10mg Dosage Protocol | PeptideDosages.com
SS-31 (10 mg Vial) Dosage Protocol SS-31 Dosage Chart SS-31 is dosed at 5 mg–10 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL. This information is for research and educa
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
SS-31 (10 mg Vial) Dosage Protocol
SS-31 Dosage Chart
SS-31 is dosed at 5 mg–10 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL. This information is for research and educational use only.
Reconstitute: Add 1.0 mL bacteriostatic water → 10 mg/mL concentration for single‑syringe convenience.
Typical daily range: 5–10 mg once daily (gradual titration); advanced protocols may reach 15–20 mg/day under supervision.
Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks.
SS‑31 (elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane[1], stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synthesis[2]. This peptide has demonstrated protective effects in preclinical models of heart failure, neurodegenerative disease, and age‑related muscle atrophy, and received FDA accelerated approval in 2025 as the first treatment for Barth syndrome[3]. This educational protocol presents a once‑daily subcutaneous approach using concentrated reconstitution for practical insulin‑syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read SS-31 Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard / Gradual Approach (1 mL = 10 mg/mL)
Weeks 1–2
5 mg (5000 mcg)
50 units (0.50 mL)
Weeks 3–8
10 mg (10,000 mcg)
100 units (1.0 mL)
Frequency: Inject once daily subcutaneously at a consistent time. This concentrated dilution (1.0 mL per 10 mg vial) keeps standard doses within a single insulin syringe for convenience and accuracy.
Reconstitution Steps
Draw 1.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid vigorous shaking to prevent foaming.
Gently swirl/roll until fully dissolved (clear solution).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 4 weeks.
Advanced / Aggressive Approach (1 mL = 10 mg/mL)
Weeks 3–4
Weeks 5–8
15 mg (15,000 mcg)
Split: 2 × 75 units (0.75 mL each)
Optional Weeks 9–12
20 mg (20,000 mcg)
Split: 2 × 100 units (1.0 mL each)
Note: Advanced dosing (15–20 mg/day) is based on short‑term clinical trial protocols[4][5] for severe mitochondrial conditions and should only be pursued under medical supervision. Doses above 10 mg require splitting into two separate subcutaneous injections at different sites. Clinical trials have not extensively evaluated SS‑31 beyond 12 weeks; extended use requires careful monitoring.
Supplies Needed
Plan based on an 8–12 week daily protocol with gradual titration.
Peptide Vials (SS‑31, 10 mg each):
8 weeks (Standard: 5–10 mg/day) ≈ 50 vials
12 weeks (Standard maintenance at 10 mg/day) ≈ 77 vials
12 weeks (Advanced: escalating to 15 mg/day) ≈ 105 vials
Insulin Syringes (U‑100, 1 mL capacity):
Per week (standard dosing): 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
Advanced protocols with split injections may require 2 syringes per day for higher doses
Bacteriostatic Water (30 mL bottles): Use 1.0 mL per vial for reconstitution.
8 weeks (50 vials): 50 mL → 2 × 30 mL bottles
12 weeks (77 vials): 77 mL → 3 × 30 mL bottles
12 weeks (105 vials, advanced): 105 mL → 4 × 30 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes